Our vision a world without deaths from fungal infection.
  • Latest News
  • Podcasts
  • Annual Reports
  • Make a donation
logo
  • Why
    • Why GAFFI?
    • Fungi and Fungal Infections
    • Treatment Deficiencies
    • Diagnostic Deficiencies
    • Fungal Disease Frequency
    • Burden of disease maps
    • SDGs and fungal diseases
  • Who
    • Board
    • Executive
    • Senior Advisors
    • Our Ambassadors
    • Partners
  • Where & How
    • Policy Briefs
    • Education
    • Demonstration Site
    • Neglected Fungal Diseases
    • Video resources
  • Resources
    • Latest News
    • GAFFI Podcasts
    • Annual Reports
    • Roadmap
    • Academic Papers
    • Fact Sheets
    • Book – Ambrosio Etoile
    • Global Fungal Infection Forum 1 – Seattle
    • Global Fungal Infection Forum 2 in Liverpool
    • Global Fungal Infection Forum 3 in Kampala
    • Global Fungal Infection Forum 4 in Lima
    • Governance and Finance Policies
  • Global Impact
    • Africa Diagnostic Report 2022
    • Antifungal drug maps
    • Burden of disease maps
    • Country Fungal Disease Burdens
    • ICD 11 Mycoses
    • Cryptococcal meningitis Africa dashboard
  • Contact
  • Search

News

Keep up to date with the latest news items from GAFFI.

Mycetoma is added to the WHO list of neglected tropical diseases

September 4, 2013

Assessment of birth defects when taking fluconazole or itraconazole

September 2, 2013

Berwick report on patient safety in the NHS (UK)

August 20, 2013

WHO reinstates Amphotericin B and flucytosine on the Essential medicines List

August 8, 2013

Ketoconazole withdrawn by FDA, for almost all indications

July 30, 2013

Nearly 5 million Asthmatics have ABPA and could benefit from Antifungal Therapy

May 8, 2013

Better Treatment For Cryptococcal Meningitis With Flucytosine In Combination With Amphotericin B

April 22, 2013

Access To Diagnosis And Treatment For Cryptococcal Meningitis

April 2, 2013

Ecdc Issues Risk Assessment On Azole Resistance In Aspergillus From Environmental Azole Fungicide.

February 28, 2013

Gaffi Advisers Meet Who’s Tuberculosis Leader Mario Raviglione

January 22, 2013

GAFFI is the sole organization committed to enhancing the diagnosis, facilitating access to treatment, and improving outcomes in HIV-associated fungal disease.

  • 1
  • …
  • 19
  • 20
  • 21
  • 22

Our vision - a world without deaths from fungal infection

Make a donation
GAFFI requires substantial funding to deliver its mission. Current fundraising is focused on major donor agencies and philanthropists from any country.
Make a donation
Get in touch
Contact us at the following addresses:
GAFFI
Rue Le Corbusier 12
1208 Geneva, Switzerland
Bridge House, Ashley Road, Hale, Altrincham
WA14 2UT, UK
Stay up to date
info@gaffi.org@gaffi_org
Foundation Number: CHE-476.655.939UK Charity number: 1170853Privacy PolicyTerms & Conditions
© 2025 Gaffi. All rights reserved